Vascular Smooth Muscle Cells in CADASIL
Overview <table class="infobox infobox-cell">
...
Vascular Smooth Muscle Cells in CADASIL
Overview <table class="infobox infobox-cell">
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary small vessel disease caused by NOTCH3 mutations affecting vascular smooth muscle cells (VSMCs) in cerebral arteries and arterioles. VSMC degeneration is the pathological hallmark of CADASIL, leading to vessel wall thickening, luminal narrowing, reduced cerebral blood flow, and ischemic brain injury. Understanding VSMC pathology in CADASIL provides insights into vascular contributions to neurodegeneration and potential therapeutic targets.
Mermaid diagram (expand to render)
CADASIL Genetics and Pathophysiology
NOTCH3 Gene
Mutation Mechanism CADASIL-causing mutations are stereotypic:
Cysteine gain/loss : Odd number of cysteines in EGF-like domainHotspots : Exons 2-24 encoding EGF-like repeatsEffect : Abnormal protein folding and aggregationInheritance : Autosomal dominant with variable penetranceNOTCH3 Structure
Extracellular domain : 34 EGF-like repeatsTransmembrane domain : Single-passIntracellular domain : Transcriptional activationLigands : Jagged1/2, Delta-like 1/3/4Vascular Smooth Muscle Cell Pathology
Granular Osmiophilic Material (GOM) The characteristic pathological finding in CADASIL:
Mermaid diagram (expand to render)
VSMC Degeneration Progressive VSMC loss through:
Protein aggregation stress : NOTCH3/GOM toxicityER stress : Unfolded protein response activationOxidative stress : Mitochondrial dysfunctionApoptosis : Programmed cell death pathwaysImpaired autophagy : Failed protein clearance
Vascular Pathology
Small Vessel Changes
Vessel Wall Changes
Intimal hyperplasia : Fibrous intimal thickeningMedia degeneration : VSMC loss, collagen depositionAdventitial fibrosis : Perivascular collagenLuminal narrowing : 30-70% reduction commonCerebral Blood Flow Reduction
Clinical Manifestations
Core Features
MRI Findings Characteristic neuroimaging features:
White matter hyperintensities : Anterior temporal, external capsuleLacunar infarcts : Basal ganglia, thalamus, brainstemCerebral microbleeds : 10-30% of patientsBrain atrophy : Frontal, temporal predominanceDisease Progression
Mermaid diagram (expand to render)
Molecular Mechanisms
NOTCH3 Signaling Disruption
Protein Aggregation Toxicity
NOTCH3 ectodomain accumulation : Progressive depositionTIMP3 recruitment : Matrix metalloproteinase inhibitionVitronectin binding : ECM remodeling disruptionClusterin aggregation : Chaperone system overload
Secondary Pathogenic Mechanisms
Relationship to Other Neurodegenerative Disorders
Vascular Contributions to Cognitive Impairment CADASIL provides a model for understanding vascular contributions to neurodegeneration:
Overlap with Alzheimer Pathology
Amyloid deposition : Increased in CADASIL vesselsTau pathology : Secondary to ischemic injuryApoE4 association : May accelerate declineMixed dementia : CADASIL + AD pathology commonComparison with Other Vasculopathies
Diagnostic Approaches
Genetic Testing
NOTCH3 sequencing : Standard diagnostic testTargeted exons : Exons 2-24 cover 95%+ mutationsVariants of unknown significance : Clinical correlation neededSkin Biopsy
Biomarkers
Therapeutic Approaches
Current Management
Disease-Modifying Strategies
Symptomatic Treatment
Migraine : Standard prophylaxis (avoid vasoconstrictors)Depression : SSRIs, psychotherapyCognitive symptoms : Cholinesterase inhibitors (limited benefit)Gait disorder : Physical therapy
Research Directions
Clinical Trials
ESCAPE-CADASIL : Evaluating strategies for vascular protectionCADASIL-TCH : Tadalafil for cerebral blood flowAnti-aggregation : Targeting GOM formationEmerging Therapeutic Targets
Mermaid diagram (expand to render)
Biomarker Development
CSF biomarkers : NfL, tau, amyloid ratiosBlood biomarkers : NfL, GFAP, inflammatory markersImaging biomarkers : MRI, PET, ultrasoundFunctional biomarkers : CBF, vascular reactivityClinical Management Algorithm
Monitoring Recommendations
Genetic Counseling
Inheritance risk : 50% transmission to offspringVariable expressivity : Severity unpredictablePresymptomatic testing : Available with counselingFamily screening : Important for at-risk relatives[Neurons — Major brain cell type](/cell-types/neurons)](/entities/neurons)
[Glia — Support cells in the brain](/genes/th)
[Alzheimer's Disease — Related neurodegenerative disease](/genes/rel)
[Parkinson's Disease — Related neurodegenerative disease](/genes/ar)
External Links
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
Show full description